Int Ophthalmol (2018) 38:1129–1134 https://doi.org/10.1007/s10792-017-0571-x ORIGINAL PAPER Minimally invasive combined glaucoma and cataract surgery: clinical results of the smallest ab interno gel stent . . . Alessandra De Gregorio Emilio Pedrotti Luisa Russo Simonetta Morselli Received: 25 January 2017 / Accepted: 16 May 2017 / Published online: 29 May 2017 Springer Science+Business Media Dordrecht 2017 Abstract success rate was achieved in 80.4% and a qualiﬁed Purpose To verify the efﬁcacy in intraocular pres- success in 97.5%. There were no major intra- and sure (IOP) reduction and safety of the smallest gel postoperative complications during the ﬁrst year of stent (XEN 45 Gel Stent) microincisional glaucoma follow-up. surgery combined with microincisional cataract sur- Conclusions This study demonstrated that the smal- gery (MICS). ler diameter XEN 45 gel implant is statistically Methods Nonrandomized prospective clinical study. effective in reducing IOP and medications in glau- Forty-one eyes of 33 patients with open-angle glau- coma patients with a low rate of complications. coma underwent a XEN 45 Gel Stent implantation combined with MICS. Treatment outcomes analyzed Keywords Glaucoma Microincisional glaucoma included: IOP, medication use, intra- and postopera- surgery (MIGS) XEN Gel Stent Filtration surgery tive complications. At the end of
International Ophthalmology – Springer Journals
Published: May 29, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera